FIRST START 100
LIVE

Serial Number

79408337

Owner

Glanbia Nutritionals Limited

Attorney

Caroline Bryce

Filing Date

Aug 26, 2024

Add to watchlist:

No watchlists yet
View on USPTO

FIRST START 100 Trademark

Serial Number: 79408337

FIRST START 100 is a trademark filed by Glanbia Nutritionals Limited on August 26, 2024. The trademark is classified under Class 5 (Pharmaceuticals). The application is currently pending registration.

Owner Contact Info

Glanbia Nutritionals Limited

Glanbia House

Entity Type: 99

Trademark Details

Filing Date

August 26, 2024

Registration Date

Not Registered

Goods & Services

Dietary and nutritional supplements for animals.

Filing History

NOTIFICATION FOR REQ FOR RECON DENIED NO APPEAL FILED
Apr 29, 2026 RDX3
ACTION FOR REQ FOR RECON DENIED NO APPEAL FILED E-MAILED
Apr 29, 2026 RDX1
ACTION REQ FOR RECON DENIED NO APPEAL FILED COUNTED NOT MAILED
Apr 29, 2026 RRDX
NOTIFICATION OF POSSIBLE OPPOSITION - PROCESSED BY IB
Apr 16, 2026 OPNX
NOTIFICATION OF POSSIBLE OPPOSITION SENT TO IB
Mar 30, 2026 OPNS
NOTIFICATION OF POSSIBLE OPPOSITION CREATED, TO BE SENT TO IB
Mar 29, 2026 OPNR
TEAS/EMAIL CORRESPONDENCE ENTERED
Mar 24, 2026 TEME
CORRESPONDENCE RECEIVED IN LAW OFFICE
Mar 24, 2026 CRFA
TEAS REQUEST FOR RECONSIDERATION RECEIVED
Mar 24, 2026 ERFR
NOTIFICATION OF FINAL REFUSAL EMAILED
Sep 25, 2025 GNFN
FINAL REFUSAL E-MAILED
Sep 25, 2025 GNFR
FINAL REFUSAL WRITTEN
Sep 25, 2025 CNFR
TEAS/EMAIL CORRESPONDENCE ENTERED
Sep 4, 2025 TEME
CORRESPONDENCE RECEIVED IN LAW OFFICE
Sep 4, 2025 CRFA
TEAS RESPONSE TO OFFICE ACTION RECEIVED
Sep 4, 2025 TROA
REFUSAL PROCESSED BY IB
Mar 22, 2025 RFNT
NON-FINAL ACTION MAILED - REFUSAL SENT TO IB
Mar 4, 2025 RFCS
REFUSAL PROCESSED BY MPU
Mar 4, 2025 RFRR
NON-FINAL ACTION (IB REFUSAL) PREPARED FOR REVIEW
Jan 16, 2025 RFCR
NON-FINAL ACTION WRITTEN
Jan 15, 2025 CNRT
ASSIGNED TO EXAMINER
Jan 14, 2025 DOCK
APPLICATION FILING RECEIPT MAILED
Nov 4, 2024 MAFR
NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
Nov 4, 2024 NWOS
SN ASSIGNED FOR SECT 66A APPL FROM IB
Oct 31, 2024 REPR